Novavax, Inc. NVAX

10.63 0.03 0.28% as of 25 Sep
Market cap
$1.8B
P/E
0.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
2.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.97 1.79 0.52 0.39 9.29 13.49 5.14 19.84 12.20 22.40
P/FCF ratio
0.00 13.48 0.00 0.00 39.65 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(27.58) (7.07) (2.87) (6.50) (31.09) (49.92) (4.04) (15.03) (8.77) (5.33)
P/B ratio
0.00 0.00 0.00 0.00 0.00 10.23 0.00 0.00 0.00 0.00
EV/Sales
0.52 0.75 0.15 (0.19) 8.24 12.56 17.94 26.15 16.44 25.69
EV/EBITDA
1.23 0.00 0.00 0.62 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF
(2.34) 5.66 (0.20) 0.75 35.17 (61.59) (2.79) (4.82) (3.45) (1.42)
Current Ratio
2.13 0.98 0.70 0.69 0.90 2.15 3.77 2.62 2.76 4.33
Net Debt/EBITDA
(1.04) 3.54 0.68 1.87 0.72 1.08 (2.08) (1.32) (0.82) (0.19)
Debt/Equity
(1.93) (0.36) (0.31) (0.31) (0.92) 0.58 (1.72) (1.90) (3.12) (57.04)
ROE
(117.16%) 27.97% 80.69% 133.49% (1,265.71%) (189.60%) 74.98% 137.02% 342.60% (195.01%)
ROA
32.17% (11.17%) (26.88%) (27.21%) (83.85%) (47.65%) (69.67%) (72.38%) (52.75%) (71.75%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% (141.24%) (142.67%) (225.18%) (351.93%) (373.77%)
Return on Tangible Assets
78.19% (166.02%) 293.87% 142.32% 18,434.83% (49.29%) (160.07%) (180.84%) (110.96%) (107.02%)
Average Days of Receivables
34.58 57.94 110.29 15.17 144.88 201.08 146.69 0.00 0.00 0.00
Earnings Yield
40.77% (15.30%) (108.55%) (84.78%) (16.28%) (6.09%) (144.72%) (27.72%) (48.46%) (81.10%)
Free Cash Flow Yield
(23.15%) 7.42% (152.46%) (66.90%) 2.52% (1.51%) (125.26%) (27.37%) (39.08%) (80.53%)
Free Cash Flow per Share
(1.55) 0.60 (7.67) (6.51) 3.57 (1.69) (4.99) (10.07) (10.16) (20.46)
Book value per Share
(0.79) (4.10) (7.11) (8.11) (4.73) 10.90 (7.72) (9.08) (6.95) (0.41)
Free Cash Flow
(251.02) 90.74 (772.77) (508.92) 265.46 (97.16) (120.15) (186.20) (148.66) (276.97)
EV/EBIT
1.30 0.00 0.00 0.60 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates